CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,005 enrolled
Drug / intervention
Prospective observational cohort studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04853225
NCT04853225N/ACompleted
CompareCT.gov

Investigation of the Clinical, Radiological and Biological Factors Associated With Disease Progression, Phenotypes and Endotypes of COPD in China

GlaxoSmithKline·observational·Posted Apr 21, 2021·Updated Aug 20, 2025

In Brief

An observational study evaluating Prospective observational cohort study for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 2,005 participants across 41 sites.

Detailed Summary

This is a non-drug interventional cohort study, which aims to investigate the clinical, radiological and biological factors associated with disease progression in COPD in China. Participants will be recruited from multiple hospitals across Guangdong province categorized as Type A hospitals (those at prefecture-level and above) and Type B hospitals (those below prefecture-level).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesChina
CollaboratorsGuangzhou Institute of Respiratory Health (GIRH)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 21, 2021
Enrollment StartApr 22, 2020
Primary CompletionJun 25, 2024
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 5.2 years ago

Interventions

Prospective observational cohort studyother

Prospective observational cohort study